Review of nucleic acid amplification technology
Australian Health Technology Advisory Committee
Record ID 31998008647
To recommend an appropriate way forward for nucleic acid amplification (NAA) technology, due to the speed at which NAA technology is being developed and the potential importance to clinical practice of new DNA/RNA amplification tests.
Authors' results and conclusions: The major clinical applications of NAA technologies were reviewed in the following broad areas: general infectious diseases HIV/AIDS, hepatitis C and other hepatitis viruses, transplantation and blood transfusion, haematology, cancer and genetic disorders. Within these areas, evaluations were made of selected specific uses of the technology. In the area of genetic disorders, AHTAC has not made specific recommendations relating to the use of NAA technology. Rather AHTAC has provided a broad overview of the ways in which NAA technology is currently applied and used in this area.
Authors' recommendations: This review produces a series of recommendations for the use of NAA technology in the broad areas outlined above, and an overview of the current usage of NAA technology.
Authors' methods: Systematic review
Project Status: Completed
URL for project: http://www.msac.gov.au/
Year Published: 1997
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Microbiological Techniques
- Gene Amplification
- Nucleic Acids
Organisation Name: Australian Health Technology Advisory Committee
Contact Address: Naarilla Hirsch, Australian Institute of Health and Welfare Health Technology Unit, GPO Box 570, Canberra, ACT, 2601, Australia
Copyright: Australian Health Technology Advisory Committee
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.